Evidence map›Paper›PMID 35831103›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Concomitant Pancreatic Ductal Adenocarcinoma and Type 1 Autoimmune Pancreatitis: A Potential Issue in the Diagnosis of Carcinoma by Endoscopic Ultrasound-guided Fine-needle Biopsy.

Kenta Kachi, Itaru Naitoh, Tesshin Ban, Kazuki Hayashi, Michihiro Yoshida, Yasuki Hori, Makoto Natsume, Akihisa Kato, Yusuke Kito, Kenta Saito and 6 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Kenta KachiDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Itaru NaitohDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Tesshin BanDepartment of Gastroenterology and Hepatology, Gamagori Municipal Hospital, Japan.
Kazuki HayashiDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Michihiro YoshidaDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Yasuki HoriDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Makoto NatsumeDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Akihisa KatoDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Yusuke KitoDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Kenta SaitoDepartment of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Japan.
Yoichi MatsuoDepartment of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Japan.
Hiroyuki KatoDepartment of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Japan.
Aya Naiki-ItoDepartment of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Japan.
Satoru TakahashiDepartment of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Japan.
Kenji NotoharaDepartment of Anatomic Pathology, Kurashiki Central Hospital, Japan.
Hiromi KataokaDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan.
Nagoya City University · JPKumamoto City Hospital · JPKurashiki Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 64-year-old man with concomitant pancreatic ductal adenocarcinoma (PDAC) and type 1 autoimmune pancreatitis (AIP). An endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) from the pancreatic head mass revealed level 2 histology of AIP and atypical glands. We diagnosed definitive focal AIP using the clinical diagnostic criteria. Computed tomography revealed that the pancreatic mass had not been reduced by steroid therapy. Surgery was performed after a histological PDAC diagnosis was made via a transpapillary biliary biopsy. The resected specimen revealed PDAC associated with AIP. It is important to consider the cooccurrence of PDAC and AIP even if the histological diagnosis via an EUS-FNB is AIP.

Indexed as

Autoimmune DiseasesAutoimmune PancreatitisCarcinoma, Pancreatic DuctalPancreatic NeoplasmsPancreatitisBiopsy, Fine-NeedleEndoscopic Ultrasound-Guided Fine Needle AspirationHumansMaleMiddle AgedUltrasonography, Interventionalautoimmune pancreatitisendoscopic ultrasound-guided fine-needle biopsypancreatic ductal adenocarcinomasteroid pulse therapy

Identifiers

PMID35831103
PMCPMC10017232
OpenAlexW4285414427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.